These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 37167097

  • 1. Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer.
    Sun Y, Sun Q, Tian J, He X.
    J Clin Endocrinol Metab; 2023 Oct 18; 108(11):e1413-e1423. PubMed ID: 37167097
    [Abstract] [Full Text] [Related]

  • 2. Radioactive Iodine Therapy Decreases the Recurrence of Intermediate-Risk PTC With Low Thyroglobulin Levels.
    Tian T, Qi Z, Huang S, Wang H, Huang R.
    J Clin Endocrinol Metab; 2023 Jul 14; 108(8):2033-2041. PubMed ID: 36715264
    [Abstract] [Full Text] [Related]

  • 3. Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatment.
    Guy A, Hirsch D, Shohat T, Bachar G, Tirosh A, Robenshtok E, Shimon I, Benbassat CA.
    J Clin Endocrinol Metab; 2014 Nov 14; 99(11):4167-73. PubMed ID: 25157544
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
    Xu S, Huang H, Huang Y, Qian J, Wang X, Xu Z, Liu S, Liu J.
    JAMA Surg; 2023 Jan 01; 158(1):73-79. PubMed ID: 36449303
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Response to Treatment is Highly Predictable in cN0 Patients with Papillary Thyroid Carcinoma.
    Gorshtein A, Benbassat C, Robenshtok E, Shimon I, Hirsch D.
    World J Surg; 2016 Sep 01; 40(9):2123-30. PubMed ID: 27094559
    [Abstract] [Full Text] [Related]

  • 8. Impact of delayed radioiodine therapy in intermediate-/high-risk papillary thyroid carcinoma.
    Kim M, Han M, Jeon MJ, Kim WG, Kim IJ, Ryu JS, Kim WB, Shong YK, Kim TY, Kim BH.
    Clin Endocrinol (Oxf); 2019 Sep 01; 91(3):449-455. PubMed ID: 31102417
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma.
    Kim Y, Roh JL, Song D, Cho KJ, Choi SH, Nam SY, Kim SY.
    J Surg Oncol; 2020 Oct 01; 122(5):906-913. PubMed ID: 32588461
    [Abstract] [Full Text] [Related]

  • 11. Long-term clinical outcomes and prognostic factors for patients with papillary thyroid carcinoma with other organ invasions after adjuvant radioactive iodine.
    Kawamoto T, Shikama N, Fukumori T, Hoshi M, Yamada T.
    Endocrine; 2023 Apr 01; 80(1):79-85. PubMed ID: 36367673
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. De-differentiation of papillary thyroid carcinoma into squamous cell carcinoma in an elderly patient: A case report.
    Thewjitcharoen Y, Krittiyawong S, Butadej S, Nakasatien S, Polchart S, Junyangdikul P, Kanchanapituk A, Himathongkam T.
    Medicine (Baltimore); 2020 Apr 01; 99(16):e19892. PubMed ID: 32312017
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study.
    de Castro TP, Waissmann W, Simões TC, de Mello RC, Carvalho DP.
    Clin Endocrinol (Oxf); 2016 Sep 01; 85(3):466-74. PubMed ID: 26834009
    [Abstract] [Full Text] [Related]

  • 16. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
    Weitzman RE, Justicz NS, Kamani D, Kyriazidis N, Chen MH, Randolph GW.
    Laryngoscope; 2022 Sep 01; 132(9):1883-1887. PubMed ID: 35229306
    [Abstract] [Full Text] [Related]

  • 17. Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
    Llamas-Olier AE, Cuéllar DI, Buitrago G.
    Thyroid; 2018 Oct 01; 28(10):1311-1317. PubMed ID: 30105948
    [Abstract] [Full Text] [Related]

  • 18. Factors Influencing the Success of the First Radioiodine Therapy for Differentiated Thyroid Carcinoma.
    Claimon A, Pusuwan P, Khiewvan B.
    J Med Assoc Thai; 2017 Feb 01; 100(2):207-18. PubMed ID: 29916638
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients.
    Kim KJ, Kim SM, Lee YS, Chung WY, Chang HS, Park CS.
    Ann Surg Oncol; 2015 Jan 01; 22(1):125-31. PubMed ID: 25092159
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.